Increased proportion of B cell hybridomas secreting monoclonal antibodies of desired specificity in cultures containing macrophage-derived hybridoma growth factor (IL-6)
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 116 (2) , 245-249
- https://doi.org/10.1016/0022-1759(89)90210-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Role of the macrophage-derived hybridoma growth factor in the in vitro and in vivo proliferation of newly formed B cell hybridomas.The Journal of Immunology, 1987
- B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF).The EMBO Journal, 1987
- Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulinNature, 1986
- The production of more useful monoclonal antibodies I. Modifications of the basic technologyImmunology Today, 1986
- A Macrophage-Derived Factor Required by Plasmacytomas for Survival and Proliferation in VitroScience, 1986
- Enhancing the establishment efficiency of hybridoma cellsJournal of Immunological Methods, 1986
- The influence of murine macrophage-conditioned medium on cloning efficiency, antibody synthesis, and growth rate of hybridomasJournal of Immunological Methods, 1985
- Estimation of the number of monoclonal hybridomas in a cell fusion experiment. Effect of post-fusion cell dilution on hybridoma survivalJournal of Immunological Methods, 1981
- Production of monoclonal antibodies: Strategy and tacticsJournal of Immunological Methods, 1980
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975